Back to Search Start Over

Clinicopathological and prognostic significance of BCL2, BCL6, MYC, and IRF4 copy number gains and translocations in follicular lymphoma: a study by FISH analysis.

Authors :
Kim, Meejeong
Hwang, Hee Sang
Son, Eun Mi
Cho, Hyungwoo
Yoon, Dok Hyun
Suh, Cheolwon
Park, Chan Sik
Go, Heounjeong
Huh, Jooryung
Source :
Leukemia & Lymphoma. Dec2020, Vol. 61 Issue 14, p3342-3350. 9p.
Publication Year :
2020

Abstract

BCL2 translocation is the genetic hallmark of follicular lymphoma (FL). Besides BCL2 translocation, copy number (CN) gains and translocations of BCL6, MYC, and IRF4 have also been detected in FL, but there is little information regarding their prognostic significance. This retrospective study used fluorescence in situ hybridization (FISH) to analyze BCL2, BCL6, MYC, and IRF4 translocations and CN gains in 105 FL cases. Genetic translocations were detected for BCL2 (n = 64; 72.7%), BCL6 (n = 14; 15.9%), and MYC (n = 2; 2.3%); no case showed IRF4 translocation. Overall, 23 (26.1%), 30 (34.1%), 12 (13.8%), and 10 (11.0%) cases showed CN gains in BCL2, BCL6, MYC, and IRF4, respectively. BCL6 CN gain was a prognostic factor for worse overall survival, demonstrating a trend toward significance in multivariate analysis (HR =8.769, p = 0.056). BCL6 CN gain in FL might be associated with aggressive biologic behavior. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10428194
Volume :
61
Issue :
14
Database :
Academic Search Index
Journal :
Leukemia & Lymphoma
Publication Type :
Academic Journal
Accession number :
147712264
Full Text :
https://doi.org/10.1080/10428194.2020.1815017